Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antiherpesvirus agents reported by Bio-Mega/Boehringer Ingelheim

Feb. 25, 1997

Antiviral nucleoside analogues available for licensing

Feb. 24, 1997

Alpha-Beta/MycoTox antifungal collaboration

Feb. 21, 1997

New agreement reached for Searle's Maxaquin

Feb. 20, 1997

Antifungals from Schering-Plough

Feb. 20, 1997

U.S. researchers prepare chloroquine analogues

Feb. 19, 1997

Magainin lead product licensed to SKB

Feb. 17, 1997

Vaginal antifungal product cleared by FDA

Feb. 17, 1997

Neuraminidase inhibitor holds promise for flu

Feb. 14, 1997

Milestone achieved in Microcide/Pfizer collaboration

Feb. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...